EUVIMEDEUVIMED entdecken
Crossref

Goals of molecular diagnostics in type I allergy

Radoslaw Spiewak

Allergopedia · 2026 · 2 · 3

DOI: 10.14320/allergopedia.20260203 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Allergopedia, 2026. Verfasst von Radoslaw Spiewak. Die Arbeit nennt 11 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Since the discovery of IgE as the immunoglobulin that is pivotal in type I, or immediate type, allergy, there were attempts at its utilization in allergy diagnosis. Subsequent tests became increasingly technically advanced; however, one of the primary challenges was defining the allergen substrate, which determined not only sensitivity and specificity but also reproducibility and the interchangeability of tests from different manufacturers. In recent decades, promising developments in the molecular diagnostics of IgE-mediated allergic reactions has been observed, an areas also referred to as Component-Resolved Diagnostics (CRD) or Precision Allergy Molecular Diagnosis (PAMD@). This brief overview aims to outline the key goals of molecular diagnostics for type I (IgE-mediated) allergy.

Zitieren

APA

Spiewak, R. (2026). Goals of molecular diagnostics in type I allergy. Allergopedia, 2, 3. https://doi.org/10.14320/allergopedia.20260203

Vancouver

Spiewak R. Goals of molecular diagnostics in type I allergy. Allergopedia. 2026;2:3. doi:10.14320/allergopedia.20260203

BibTeX
@article{Spiewak2026,
  author = {Spiewak, Radoslaw},
  title = {Goals of molecular diagnostics in type I allergy},
  journal = {Allergopedia},
  year = {2026},
  volume = {2},
  pages = {3},
  doi = {10.14320/allergopedia.20260203}
}
Kostenlos starten →